A couple of years ago Turing Pharmaceuticals took an off-patent drug that treats HIV patients, Daraprim, and raised it by a price of 5000 percent.
Gus Bilirakis: “A couple of years ago Turing Pharmaceuticals took an off-patent drug that treats HIV patients, Daraprim, and raised it…”
Editor's note · Context
Discussing significant price hikes of off-patent drugs by pharmaceutical companies.
Share
More from Gus Bilirakis
Congress needs to do--to once again respond to the new wave of online marketing tactics that fuel Big Tech's ad-based revenue stream and enact a comprehensive... Federal data privacy law.
I am here to talk about my good friend, an outstanding leader, Chairwoman Rodgers. We are going to miss her. I am glad we can gather today, actually this evening, to recognize the outstanding leadership of Energy and Commerce Committee…
I thank the chairman of the Health Subcommittee for his leadership and for yielding me time. Madam Chair, I rise today in support of the HALT Fentanyl Act. The American people are in the midst of a staggering illicit fentanyl crisis. Our…
We are learning from those experiences, because a law that gets struck down in court does not protect a child.





